BioCentury
ARTICLE | Financial News

Novo Seeds invests €2.7M in Antag

July 6, 2017 6:35 PM UTC

On June 28, metabolic start-up Antag Therapeutics ApS (Copenhagen, Denmark) said it received a €2.7 million ($3 million) investment from Novo Seeds, the early stage investment arm of Novo Holdings A/S (Hellerup, Denmark)...

BCIQ Company Profiles

Antag Therapeutics ApS